American Cancer Society lung cancer screening guidelines

Richard Wender, Elizabeth T.H. Fontham, Ermilo Barrera, Graham A. Colditz, Timothy R. Church, David S. Ettinger, Ruth Etzioni, Christopher R. Flowers, G. Scott Gazelle, Douglas K. Kelsey, Samuel J. Lamonte, James S. Michaelson, Kevin C. Oeffinger, Ya Chen Tina Shih, Daniel C. Sullivan, William Travis, Louise Walter, Andrew M.D. Wolf, Otis W. Brawley, Robert A. Smith

Research output: Contribution to journalArticle

420 Scopus citations

Abstract

Answer questions and earn CME/CNE Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation.

Original languageEnglish (US)
Pages (from-to)106-117
Number of pages12
JournalCA Cancer Journal for Clinicians
Volume63
Issue number2
DOIs
StatePublished - Jan 1 2013

    Fingerprint

Keywords

  • adverse effects
  • computed tomography
  • humans
  • lung cancer screening
  • lung neoplasms
  • mortality
  • radiation dosage
  • radiography
  • randomized controlled trials as topic
  • risk
  • risk reduction behavior
  • x-ray

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., Lamonte, S. J., Michaelson, J. S., Oeffinger, K. C., Shih, Y. C. T., Sullivan, D. C., Travis, W., Walter, L., Wolf, A. M. D., Brawley, O. W., & Smith, R. A. (2013). American Cancer Society lung cancer screening guidelines. CA Cancer Journal for Clinicians, 63(2), 106-117. https://doi.org/10.3322/caac.21172